Phase I/II study to evaluate the feasibility and efficacy of sequential abemaciclib and gemcitabine treatment in patients with retinoblastoma (Rb)-positive leiomyosarcoma (LMS) and dedifferentiated liposarcoma (DDLPS).

Authors: Elise F. Nassif Haddad, Khandan Keyomarsi, Heather Y. Lin, Alexander J. Lazar, Wei-Lien Wang, Charles Manning, Guofan Xu, Osama F Mawlawi, Lorraine Cheryl Pelosof, Kelly Hunt, Funda Meric-Bernstam, Neeta Somaiah

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11583

Source: Full article

---

Abstract

TPS11583